66 studies found for:    telomerase
Show Display Options
Rank Status Study
1 Unknown  Pulmonary Fibrosis and Telomerase Mutation Study
Condition: Pulmonary Fibrosis
2 Terminated Telomere and Telomerase
Condition: Acute Myeloid Leukemia
Intervention: Genetic: Blood  sample
3 Recruiting Qigong Intervention Program for Abused Chinese Women
Condition: Abused Women
Interventions: Behavioral: Qigong training;   Other: Wait-list control- Health talks
4 Unknown  Telomerase Activity as a Marker For Mobilization Quality
Conditions: Lymphoma;   Multiple Myeloma
5 Withdrawn Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines
Condition: Metastatic Prostate Cancer
Intervention: Biological: hTERT mRNA DC
6 Active, not recruiting A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: GRN163L in combination with trastuzumab
7 Completed GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: GV 1001 Telomerase peptide
8 Not yet recruiting Telomeres Evaluation in Endometriosis
Condition: Endometriosis
Intervention: Procedure: tissue biopsy during surgical treatment
9 Active, not recruiting Radiation Therapy, Tadalafil, Sargramostim, Gemcitabine, and Telomerase Vaccine (GV1001) in Patients With Pancreatic Cancer
Condition: Locally Advanced Pancreatic Adenocarcinoma
Intervention: Biological: tadalafil and vaccination
10 Withdrawn Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma
Conditions: Solid Tumors;   Lymphoma
Intervention: Drug: Imetelstat
11 Recruiting Telomeres Parameters in Cirrhosis
Condition: Cirrhosis
12 Recruiting Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Ependymoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma
Interventions: Drug: imetelstat sodium;   Other: laboratory biomarker analysis;   Other: pharmacological study
13 Completed Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
Condition: Malignant Melanoma
Intervention: Biological: GV1001
14 Recruiting Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts
Condition: Urothelial Carcinoma of the Bladder
Intervention: Other: Blood Collection
15 Terminated The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
Conditions: Metabolic Syndrome;   Insulin Resistance
Interventions: Dietary Supplement: TA-65;   Dietary Supplement: Placebo
16 Completed Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
Conditions: Brain and Central Nervous System Tumors;   Gastrointestinal Stromal Tumor;   Sarcoma
Interventions: Biological: sargramostim;   Biological: telomerase: 540-548 peptide vaccine
17 Unknown  Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Biological: incomplete Freund's adjuvant;   Biological: sargramostim;   Biological: telomerase: 540-548 peptide vaccine
18 Completed Vaccine Therapy in Treating Patients With Metastatic Cancer
Conditions: Melanoma (Skin);   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: aldesleukin;   Biological: incomplete Freund's adjuvant;   Biological: telomerase: 540-548 peptide vaccine
19 Not yet recruiting Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer
Condition: Inoperable Stage III Non-small Cell Lung Cancer
Interventions: Drug: GV1001;   Drug: normal saline
20 Unknown  A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
Conditions: Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma
Intervention: Biological: CB-10-01 (Transgenic Lymphocyte Immunization)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years